Global Pharmacovigilance and Drug Safety Software Market 2019-2023
SKU ID : TNV-14416294 | Publishing Date : 26-Jun-2019 | No. of pages : 121
Detailed TOC of Global Pharmacovigilance and Drug Safety Software Market 2019-2023
PART 01: EXECUTIVE SUMMARYPART 02: SCOPE OF THE REPORT
2.1 Preface
2.2 Preface
2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
Market ecosystem
Market characteristics
Market segmentation analysis
PART 04: MARKET SIZING
Market definition
Market sizing 2018
Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition
PART 06: MARKET SEGMENTATION BY END-USER
Market segmentation by end-user
Comparison by end-user
Pharmaceutical and biotechnology companies -
Market size and forecast 2018-2023
Contract research organization - Market size and forecast 2018-2023
Business process outsourcing - Market size and forecast 2018-2023
Market opportunity by end-user
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2018-2023
Europe - Market size and forecast 2018-2023
Asia - Market size and forecast 2018-2023
ROW - Market size and forecast 2018-2023
Key leading countries
Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
Market drivers
Market challenges
PART 11: MARKET TRENDS
Integration of AI in pharmacovigilance
Outsourcing pharmacovigilance and drug safety research to CROs
Extensive adoption of cloud technologies in pharmaceutical manufacturing and testing
PART 12: VENDOR LANDSCAPE
Overview
Landscape disruption
PART 13: VENDOR ANALYSIS
Vendors covered
Vendor classification
Market positioning of vendors
AB Cube
ArisGlobal LLC
Ennov
EXTEDO GmbH
Oracle Corp.
PART 14: APPENDIX
Research methodology
List of abbreviations
Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO
Exhibit 01: Global healthcare market
Exhibit 02: Segments of global healthcare market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: End-user - Market share 2018-2023 (%)
Exhibit 18: Comparison by end-user
Exhibit 19: Pharmaceutical and biotechnology companies - Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Pharmaceutical and biotechnology companies - Year-over-year growth 2019-2023 (%)
Exhibit 21: Contract research organization - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Contract research organization - Year-over-year growth 2019-2023 (%)
Exhibit 23: Business process outsourcing - Market size and forecast 2018-2023 ($ millions)
Exhibit 24: Business process outsourcing - Year-over-year growth 2019-2023 (%)
Exhibit 25: Market opportunity by end-user
Exhibit 26: Customer landscape
Exhibit 27: Market share by geography 2018-2023 (%)
Exhibit 28: Geographic comparison
Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 30: North America - Year-over-year growth 2019-2023 (%)
Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 32: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 34: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 35: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 36: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 37: Key leading countries
Exhibit 38: Market opportunity
Exhibit 39: Impact of drivers and challenges
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: AB Cube - Vendor overview
Exhibit 46: AB Cube - Business segments
Exhibit 47: AB Cube - Organizational developments
Exhibit 48: AB Cube - Key offerings
Exhibit 49: ArisGlobal LLC - Vendor overview
Exhibit 50: ArisGlobal LLC - Product segments
Exhibit 51: ArisGlobal LLC - Organizational developments
Exhibit 52: ArisGlobal LLC - Key offerings
Exhibit 53: Ennov - Vendor overview
Exhibit 54: Ennov - Business segments
Exhibit 55: Ennov - Organizational developments
Exhibit 56: Ennov - Key offerings
Exhibit 57: EXTEDO GmbH - Vendor overview
Exhibit 58: EXTEDO GmbH - Business segments
Exhibit 59: EXTEDO GmbH - Organizational developments
Exhibit 60: EXTEDO GmbH - Key offerings
Exhibit 61: Oracle Corp. - Vendor overview
Exhibit 62: Oracle Corp. - Business segments
Exhibit 63: Oracle Corp. - Organizational developments
Exhibit 64: Oracle Corp. - Geographic focus
Exhibit 65: Oracle Corp. - Segment focus
Exhibit 66: Oracle Corp. - Key offerings
Exhibit 67: Validation techniques employed for market sizing
Exhibit 68: Definition of market positioning of vendors
Keyplayers in Global Pharmacovigilance and Drug Safety Software Market 2019-2023
AB CubeArisGlobal LLC
Ennov
EXTEDO GmbH
Oracle Corp.